Austgen M
Pneumologie. 1989 Feb;43(2):88-91.
Radioactive substances are widely used in the treatment of malignant pleural and peritoneal effusions. Since the instillation of radioactive 198Au rarely yielded long-term therapeutic successes, we examined the effect of 90yttrium silicate in intrapleural instillation. In 74 patients suffering from pleural effusion characterised by a rapid an high relapse tendency, the malignant genesis of the effusion having been confirmed histologically by thoracoscopy or cytologically, 50 mCi of 90yttrium silicate were instilled intrapleurally after maximally complete drainage of the exudate via puncture. In all patients the production of the effusion was clearly reduced under this therapy or was at least temporarily completely discontinued. 63 patients died since initiation of therapy. Their average survival time was about 288 days. 11 patients are still under outpatient follow-up control and did not show any repeated formation of an effusion. No significant side effects have been recorded so far, neither subjectively nor haematologically or via chemical examination in the laboratory.
放射性物质广泛应用于恶性胸腔积液和腹腔积液的治疗。由于注入放射性198Au很少能取得长期治疗成功,我们研究了硅酸钇90用于胸腔内注入的效果。在74例胸腔积液复发快且倾向高的患者中,经胸腔镜组织学或细胞学检查确诊积液的恶性来源,通过穿刺最大程度完全引流渗出液后,向胸腔内注入50毫居里硅酸钇90。在这种治疗下,所有患者的积液产生明显减少,或至少暂时完全停止。自治疗开始以来,63例患者死亡。他们的平均生存时间约为288天。11例患者仍在门诊随访中,未出现积液再次形成的情况。迄今为止,无论是主观上、血液学上还是实验室化学检查,均未记录到明显的副作用。